Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation Naccarelli GV; Peacock FVasc Health Risk Manag 2009[]; 5 (ä): 783-91Atrial fibrillation (AF) is the most common form of cardiac arrhythmia and is associated with an increased risk of cardiovascular morbidity and mortality, especially due to ischemic stroke. The occurrence of AF leads to atrial electrical and structural remodeling. The renin-angiotensin system appears to play a role in the development of atrial arrhythmias by its involvement in both of these processes. Large-scale hypertension trials and heart failure trials have indicated the potential value of angiotensin II receptor blockers in the treatment of AF.|Angiotensin II Type 1 Receptor Blockers/*therapeutic use[MESH]|Atrial Fibrillation/complications/*drug therapy/physiopathology[MESH]|Clinical Trials as Topic[MESH]|Electric Countershock[MESH]|Evidence-Based Medicine[MESH]|Humans[MESH]|Recurrence[MESH]|Renin-Angiotensin System/*drug effects[MESH]|Stroke/etiology/physiopathology/*prevention & control[MESH]|Treatment Outcome[MESH] |